High Impact Drug Classes

In part 4 of our 2023 drug trends series, we’re evaluating workers’ comp high impact drug class patterns and strategies to address the challenges these cost drivers are creating.

Infographic Summary

High impact drug categories represent proportionately low utilization; however, they can be associated with exponentially significant costs. Part 4 of our annual drug trends series recognizes the trends related to these cost drivers to help promote clinically appropriate savings. In our final report for 2023, we address prescription trends related to topicals, compound kits, combo packs, and specialty medications.

To view future installments of the drug trends series, be sure to visit our drug trends page.

Register to download the full content


To learn more from Enlyte, please visit their website.

Enlyte is the parent brand of Mitchell | Genex | Coventry, a leader in cost-containment technology, independent medical exams (IME), provider and specialty networks, case management services, pharmacy benefit and disability management. The three businesses have recently aligned their joint industry expertise and advanced technology solutions into a combined organization of nearly 6,000 associates committed to simplifying and optimizing property, casualty and disability claims processes and services.

More from Risk & Insurance